Natural Product: NPC546702

Natural Product IDNPC546702
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(1~{R},2~{R},5~{S},8~{R},9~{S},10~{R},13~{R},14~{R},15~{S},16~{R},18~{R})-15-formyl-16-hydroxy-8-isopropenyl-1,2,14,17,17-pentamethyl-pentacyclo[11.7.0.0^{2,10}.0^{5,9}.0^{14,18}]icosane-5-carboxylic acid
IUPAC Name (1~{R},2~{R},5~{S},8~{R},9~{S},10~{R},13~{R},14~{R},15~{S},16~{R},18~{R})-15-formyl-16-hydroxy-8-isopropenyl-1,2,14,17,17-pentamethyl-pentacyclo[11.7.0.0^{2,10}.0^{5,9}.0^{14,18}]icosane-5-carboxylic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SLWJVQQNDGLXTK-PYIFJILSSA-N
Standard InCHI InChI=1S/C30H46O4/c1-17(2)18-10-13-30(25(33)34)15-14-27(5)19(23(18)30)8-9-22-28(27,6)12-11-21-26(3,4)24(32)20(16-31)29(21,22)7/h16,18-24,32H,1,8-15H2,2-7H3,(H,33,34)/t18-,19+,20+,21-,22-,23-,24+,27+,28+,29-,30-/m0/s1
SMILES C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)[C@H](C=O)[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   470.34 Volume:   511.905
?
Van der Waals volume.
Dense:   0.919 LogP:   3.533
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.012
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.579
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   27.0
TPSA:   74.6
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   5.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.385 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.075 Fsp3:   0.867
MCE-18:   105.857
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.885 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.005
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.323 Promiscuous compounds:   0.098

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.356 MDCK Permeability:   -5.028
Pgp-inhibitor:   0.007 Pgp-substrate:   0.002
PAMPA:   0.917
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.378 30% Bioavailability (F30%):   0.353
50% Bioavailability (F50%):   0.982

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.52 MRP1:   0.875
Plasma Protein Binding (PPB):   95.58% Volume Distribution (VD):   -0.308
Fu: 5.102%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   0.776 BCRP inhibitor:   0.03
BSEP inhibitor:   0.979

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.182 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.11 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.022 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.046
HLM stability:   0.014
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.395 Half-life (T1/2):  1.048

ADMET: Toxicity

hERG Blockers:  0.022 hERG Blockers (10um):  0.038
Human Hepatotoxicity (H-HT):  0.547 Drug-induced Liver Injury (DILI):  0.407
AMES Toxicity:  0.301 Rat Oral Acute Toxicity:  0.299
Maximum Recommended Daily Dose:  0.232 Skin Sensitization:  0.973
Carcinogencity:  0.793 Eye Corrosion:  0.06
Eye Irritation:  0.439 Respiratory Toxicity:  0.741
Drug-induced Neurotoxicity:  0.057 Ototoxicity:  0.837
Hematotoxicity:  0.632 Drug-induced Nephrotoxicity:  0.854
Genotoxicity:  0.846 RPMI-8226 Immunitoxicity:  0.037
A549 Cytotoxicity:  0.067 Hek293 Cytotoxicity:  0.128
BCF:   0.711
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.551
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.046
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.494
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO50707 Zizyphus jujuba Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23278 Colubrina granulosa Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO60556 Zizphus cambodiana n.a. n.a. n.a. n.a. n.a. n.a. Database[COCONUT]
NPO23278 Colubrina granulosa Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC546702 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC24772
0.7797 Intermediate Similarity NPC80590
0.746 Intermediate Similarity NPC486704
0.7333 Intermediate Similarity NPC116146
0.6825 Remote Similarity NPC488506
0.6825 Remote Similarity NPC220498
0.6667 Remote Similarity NPC264317
0.6667 Remote Similarity NPC294438
0.6562 Remote Similarity NPC211162
0.6562 Remote Similarity NPC183374
0.6308 Remote Similarity NPC488164
0.6308 Remote Similarity NPC264005
0.625 Remote Similarity NPC119743
0.6212 Remote Similarity NPC195395
0.6212 Remote Similarity NPC201655
0.6061 Remote Similarity NPC291373
0.6061 Remote Similarity NPC213832
0.6032 Remote Similarity NPC246445
0.6032 Remote Similarity NPC68828
0.6029 Remote Similarity NPC474719
0.6 Remote Similarity NPC192744
0.5942 Remote Similarity NPC488165
0.5882 Remote Similarity NPC2783
0.5882 Remote Similarity NPC16377
0.5857 Remote Similarity NPC169933
0.5797 Remote Similarity NPC475061
0.5797 Remote Similarity NPC488213
0.5735 Remote Similarity NPC277399
0.5652 Remote Similarity NPC4309
0.5652 Remote Similarity NPC151191
0.5634 Remote Similarity NPC601176
0.5571 Remote Similarity NPC269360
0.5571 Remote Similarity NPC601275
0.5513 Remote Similarity NPC486709
0.5507 Remote Similarity NPC271974
0.5507 Remote Similarity NPC247312
0.5493 Remote Similarity NPC160506
0.5417 Remote Similarity NPC607677
0.5366 Remote Similarity NPC290349
0.5309 Remote Similarity NPC486699
0.5278 Remote Similarity NPC611139
0.5244 Remote Similarity NPC486695
0.5217 Remote Similarity NPC30583
0.5205 Remote Similarity NPC478841
0.5205 Remote Similarity NPC488166
0.5205 Remote Similarity NPC600004
0.5205 Remote Similarity NPC608379
0.5122 Remote Similarity NPC486708

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC546702 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6667 Remote Similarity NPD7520 Phase 1
0.5493 Remote Similarity NPD8035 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data